Discussing complementary therapies: there's more than efficacy to consider.
作者信息
Truant T, McKenzie M
出版信息
CMAJ. 1999 Feb 9;160(3):351-2.
Abstract
摘要
相似文献
1
Discussing complementary therapies: there's more than efficacy to consider.讨论辅助疗法：需要考虑的不仅仅是疗效。
CMAJ. 1999 Feb 9;160(3):351-2.
2
Discussing do-not-resuscitate status.讨论“不要复苏”状态。
J Clin Oncol. 2001 Mar 1;19(5):1576-81. doi: 10.1200/JCO.2001.19.5.1576.
3
Communication in cancer care: discussing complementary and alternative medicine.癌症护理中的沟通：讨论补充和替代医学。
Integr Cancer Ther. 2010 Jun;9(2):177-85. doi: 10.1177/1534735410363706. Epub 2010 Mar 31.
4
Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.评估证据在患者对补充疗法评估中的作用：一项质量研究。
Integr Cancer Ther. 2007 Dec;6(4):345-53. doi: 10.1177/1534735407309482.
5
Use of complementary therapies during chemotherapy: influence of patients' satisfaction with treatment decision making and the treating oncologist.化疗期间补充疗法的使用：患者对治疗决策及主治肿瘤学家满意度的影响
Integr Cancer Ther. 2006 Sep;5(3):224-31. doi: 10.1177/1534735406291494.
6
A humanist looks at the mind/body connection.一位人文主义者关注身心联系。
J Med Assoc Ga. 1994 Nov;83(11):607-11.
7
Enhancing doctor-patient communication.加强医患沟通。
J Clin Oncol. 2001 Sep 15;19(18 Suppl):61S-63S.
8
Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine.让我们来谈谈你正在服用的那些草药：与癌症患者就补充和替代医学进行沟通的伦理考虑。
J Oncol Pract. 2019 Jan;15(1):44-49. doi: 10.1200/JOP.18.00432.
9
[Communication between cancer patients and physicians regarding unconventional treatments].[癌症患者与医生之间关于非常规治疗的沟通]
Ugeskr Laeger. 2005 May 23;167(21):2285-9.
10
There's no substitute for a family physician.家庭医生是无可替代的。
J Fam Pract. 2011 Dec;60(12):709.
引用本文的文献
1
A review of the use of complementary and alternative medicine and HIV: issues for patient care.补充和替代医学与 HIV 的使用综述：患者护理问题。
AIDS Patient Care STDS. 2013 Sep;27(9):503-10. doi: 10.1089/apc.2013.0175.
本文引用的文献
1
Drug-related mortality in Canada (1984-1994).加拿大的药物相关死亡率（1984 - 1994年）。
Pharmacoepidemiol Drug Saf. 1997 May;6(3):157-68. doi: 10.1002/(SICI)1099-1557(199705)6:3<157::AID-PDS260>3.0.CO;2-J.
2
Prostate cancer: 10. Palliative care.前列腺癌：10. 姑息治疗。
CMAJ. 1999 Feb 9;160(3):365-71.
3
The arrogance of science and the pitfalls of hope.科学的傲慢与希望的陷阱。
CMAJ. 1998 Oct 6;159(7):803-4.
4
Unconventional therapies for cancer: a refuge from the rules of evidence?癌症的非常规疗法：证据规则之外的避风港？
CMAJ. 1998 Oct 6;159(7):801-2.
5
A patient's guide to choosing unconventional therapies.患者选择非传统疗法指南。
CMAJ. 1998 May 5;158(9):1161-5.
6
Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.住院患者药物不良反应的发生率：前瞻性研究的荟萃分析
JAMA. 1998 Apr 15;279(15):1200-5. doi: 10.1001/jama.279.15.1200.
7
Alternative therapies as control behaviours used by cancer patients.替代疗法作为癌症患者所采用的控制行为。
J Adv Nurs. 1995 Oct;22(4):646-54. doi: 10.1046/j.1365-2648.1995.22040646.x.
8
Towards a reconceptualization of hope for patients with a diagnosis of cancer.对癌症诊断患者的希望进行重新概念化。
J Adv Nurs. 1993 May;18(5):701-6. doi: 10.1046/j.1365-2648.1993.18050701.x.
9
The social implications of questionable cancer therapies.有问题的癌症治疗方法所带来的社会影响。
Cancer. 1989 Apr 1;63(7):1247-50. doi: 10.1002/1097-0142(19890401)63:7<1247::aid-cncr2820630703>3.0.co;2-3.
10
Breast cancer: demands of illness.乳腺癌：疾病的要求。
Oncol Nurs Forum. 1991 Jan-Feb;18(1):75-80.
Zotero 插件